Combating Illicit Xylazine Act

# Combating Illicit Xylazine Act (HR 1266) - Summary **What the Bill Does** This bill addresses the growing problem of xylazine, a powerful veterinary sedative that is increasingly being mixed into illegal street drugs. The legislation would increase federal penalties for illegally manufacturing and distributing xylazine, and it directs the U.S. Sentencing Commission to establish stricter sentencing guidelines for xylazine-related crimes. The bill also aims to improve oversight of legitimate xylazine production and sales to prevent diversion to illegal drug markets. **Who It Affects and Key Provisions** The bill primarily affects drug manufacturers, distributors, and individuals involved in illegal drug trafficking.

It would also impact veterinarians and legitimate pharmaceutical companies that produce xylazine for lawful purposes through stricter regulations and licensing requirements. Additionally, it affects the criminal justice system by raising penalties for those caught making or selling illegal xylazine, potentially resulting in longer prison sentences. **Current Status** As of now, HR 1266 is in committee and has not yet been voted on by the full House. The bill remains in the early stages of the legislative process and would need committee approval and House passage before moving forward.